Bilaketaren emaitzak - Bayer Company Press Release
- Erakusten 1 - 2 emaitzak -- 2
-
1
Bayer registered a new indication for rivaroxaban for use in patients with coronary heart disease or peripheral artery disease in the European Union and USA nork Bayer Company Press Release
Argitaratua 2018Sailkapena: Lanean...Connect to this object online.
Kokapena: Lanean...
Liburua -
2
Bayer registered a new indication for rivaroxaban for use in patients with coronary heart disease or peripheral artery disease in the European Union and USA nork Bayer Company Press Release
Argitaratua 2018Sailkapena: Lanean...Connect to this object online.
Kokapena: Lanean...
Liburua